期刊文献+

开角型青光眼患者房水中MMP-3、TIMP-1的表达及意义 被引量:1

Expression of MMP-3,TIMP-1 in open-angle-glaucoma patients' aqueeus humor
下载PDF
导出
摘要 目的检测开角型青光眼患者房水中基质金属蛋白酶(MMP)-3及金属蛋白酶组织抑制因子(TIMP)-1的表达,并探讨其意义。方法采用酶联免疫反应(ELISA)双抗体夹心法检测开角型青光眼(A组)和年龄相关性白内障(B组)患者房水中MMP-3和TIMP-1的水平。结果A、B两组MMP-3水平分别为(68.0310±4.1400)、(69.7941±2.1315)μmol/L;TIMP-1水平分别为(6.7604±0.6632)、(3.1617±0.1603)μmol/L,MMP-3/TIMP-1分别为9.9017±0.3447、22.0592±1.0172,以上指标两组相比,P均<0.05。结论开角型青光眼患者房水中MMP-3表达,TIMP-1表达升高,二者共同促进细胞外基质的异常堆积从而参与了开角型青光眼的发病机制。 Objective To detect the expression of matrix metalloproteinase (MMP)-3 and MMP tissue inhibitor (TIMP) -1 in the aqueous humor of open-angle-glaucoma (POAG) and age-related-cataract ( ARC ) patients. Method MMP-3 and TIMP-1 levels in aqueous humor samples from patients with POAG( A group) and ARC( B group) were detected by enzyme-linked immunosorbent assay (ELISA). Results The MMP-3 levelsin A, B group were (68. 0310 ±4.1400),(69.7942 ±2. 1352) μmol/L; the TIMP-1 levels were(6. 7604±0. 6632) ,(3. 1617 ±0. 1603) μmol/L, MMP-3/TIMP-1 were 9. 9017 ±0. 3447,22. 0592 ± 1. 0172. There were significant difference in A,B groups( P 〈 0.05 ). Conclusions The expression of MMP-3 decreases and TIMP-1 upgrades in aqueous humor of POAG patients. They both encourage the paraplasm of extraeellutar matrix and participate the genesis of POAG.
出处 《山东医药》 CAS 北大核心 2008年第47期22-23,共2页 Shandong Medical Journal
基金 山东省自然科学基金资助(Y2002C32)
关键词 基质金属蛋白酶 金属蛋白酶组织抑制因子 开角型青光眼 年龄相关性白内障 房水 metalleproteinase tissue inhibitor of metalloproteinase open-angle glaucoma age-related-cataract aqueous humor
  • 相关文献

参考文献5

  • 1潘佳鸿,叶纹.基质金属蛋白酶及其在眼科的研究进展[J].国外医学(眼科学分册),2003,27(6):365-369. 被引量:5
  • 2Yue BY. The extracellular matrix and its modulation in the trabecular meshwork[J]. Sur Ophthalmol,1996,40 (5) :379-390.
  • 3Ueda J, Yue BY. Distribution of myocilin and extracellular matrix components in the comeosclcral meshwork of human eyes[ J]. Invest Ophthalmol Vis Sci, 2003,44 ( 11 ) :47724779.
  • 4Maatta M, Tervahartiala T. Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma [ J ]. J Glaucoma, 2005,14 ( 1 ) :64.
  • 5Alexander JP, Samples JR, Buskirk EM,et al. Expression of matrix metalloprotemases inhibitors by human trabecular meshwork[J]. Invest ophthalmol Vis Sci, 1991,32(4) :172-180.

二级参考文献10

  • 1Pei D,Weiss SJ. Nature . 1995
  • 2Pei D. Journal of Biological Chemistry . 1999
  • 3Pei D. Cell Research . 1999
  • 4Park HI et al. Journal of Biological Chemistry . 2000
  • 5Birkedal-Hansen H et al. Critical Reviews in Oral Biology and Medicine . 1993
  • 6Alexander JP et al. Investigative Ophthalmology . 1991
  • 7Van Wart HE et al. Proceedings of the National Academy of Sciences of the United States of America . 1990
  • 8Blavier L et al. Annals of the New York Academy of Sciences . 1999
  • 9Velasco G et al. Journal of Biological Chemistry . 1999
  • 10Parshley DE et al. Current Eye Research . 1995

共引文献4

同被引文献12

  • 1Nga AD, Yap SL, Samsudin A, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of pa- tients with primary angle closure glaucoma: a quantitative study [J]. BMC Ophthalmol,2014,24(14) :33.
  • 2Kara S, Yildirim N, Ozer A,et al. Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforminggrow th factor beta 1 in the aqueous humor and serum of patients w ithp- seudoexfoliation syndrome [ J ]. Clin Ophthalmol, 2014, 8: 305- 309.
  • 3Fountoulakis N, Labiris G, Aristeidou A, et al. Tissue inhibitor of metalloproteinase 4 in aqueous humor of patients with primary open angle glaucoma, pseudoexfoliation syndrome and pseudoexfo]iative glaucoma and its role in proteolysis imbalance [ J ]. BMC Ophthal- mol,2013,8 ( 13 ) :69.
  • 4De Groef L, Van Hove I, Dekeyster E, et al. MMPs in the neuroreti- na and optic nerve: modulators of glaucoma pathogenesis and re- pair [ J ]. Invest Ophthalmol Vis Sci, 2014,55 ( 3 ) : 1953-1964.
  • 5De Groef L, Van Hove I, Dekeyster E,et al. MMPs in the trabecu- lar meshwork : promising targets for future glaucoma therapies[ J]. Invest Ophthalmol Vis Sci,2013,54(12) :7756-7763.
  • 6Kim B, Abdel-Rahman MH, Wang T, et al. Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimen- tal retinal detachment [ J ]. Invest Ophthalmol Vis Sci, 2014,55 (4) :2031-2040.
  • 7郭冉阳,刘利莉,付文丽.OCT测量视网膜神经纤维层厚度及视盘参数在青光眼早期诊断中的应用及意义[J].眼科新进展,2011,31(9):854-856. 被引量:17
  • 8胡倩倩,吴仁毅.青光眼视神经保护的治疗现状及进展[J].国际眼科杂志,2014,14(4):633-636. 被引量:8
  • 9周广明,严良.MMPs在原发性开角型青光眼中的表达[J].中国实用眼科杂志,2014,32(7):813-816. 被引量:2
  • 10李苑碧,彭清华.原发性开角型青光眼发病机制及其中西医治疗研究进展[J].辽宁中医药大学学报,2014,16(8):146-149. 被引量:16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部